Knockdown of LncRNA H19 using specific siRNA in TMZ-resistant U87 and U251 cell lines restored sensitivity to TMZ, highlighting LncRNA H19 as a significant factor in GBM cell acquisition of TMZ resistance (50). The gene discussed is H19; the disease is glioblastoma.